BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9790780)

  • 1. Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities?
    Kaufman RH; Adam E
    Gynecol Oncol; 1998 Sep; 70(3):317-8. PubMed ID: 9790780
    [No Abstract]   [Full Text] [Related]  

  • 2. Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities?
    Fait G; Daniel Y; Kupferminc MJ; Lessing JB; Niv J; Bar-Am A
    Gynecol Oncol; 1998 Sep; 70(3):319-22. PubMed ID: 9790781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to consider HPV testing in cervical screening.
    Cuzick J
    Ann Oncol; 2001 Nov; 12(11):1511-4. PubMed ID: 11822748
    [No Abstract]   [Full Text] [Related]  

  • 4. Human Papillomavirus DNA detection for cervical cancer screening.
    Press RD
    Mol Diagn; 2000 Sep; 5(3):245-7. PubMed ID: 11186127
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of human papillomavirus deoxyribonucleic acid assay and repeated cervical cytologic examination in the detection of cervical intraepithelial neoplasia among human immunodeficiency virus-infected women. Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network.
    Cohn JA; Gagnon S; Spence MR; Harrison DD; Kluzak TR; Langenberg P; Brinson C; Stein A; Hellinger J;
    Am J Obstet Gynecol; 2001 Feb; 184(3):322-30. PubMed ID: 11228481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV testing for cervical neoplasia.
    Carozzi F; Confortini M; Cecchini S; Ciatto S
    Acta Cytol; 2001; 45(4):659-61. PubMed ID: 11480738
    [No Abstract]   [Full Text] [Related]  

  • 7. HPV testing is not useful for LSIL Triage--but stay tuned.
    Stoler MH
    Adv Anat Pathol; 2001 May; 8(3):160-4. PubMed ID: 11345239
    [No Abstract]   [Full Text] [Related]  

  • 8. HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study.
    Kelly RS; Patnick J; Kitchener HC; Moss SM;
    Br J Cancer; 2011 Sep; 105(7):983-8. PubMed ID: 21897395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated human papillomavirus analysis as an adjunct for triage of atypical cervical cytology.
    Cheung AN; Wong OG; Chan KK; Yang MS; Tsang CH; Ji SL; Lo CK; Szeto E; Wong E; Ngan HY
    Hong Kong Med J; 2014 Dec; 20 Suppl 6():44-7. PubMed ID: 25482973
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of HC2 to triage women with borderline and mild dyskaryosis in the UK.
    Arbyn M; Roelens J; Martin-Hirsch P; Leeson S; Wentzensen N
    Br J Cancer; 2011 Sep; 105(7):877-80. PubMed ID: 21952649
    [No Abstract]   [Full Text] [Related]  

  • 11. Have we resolved how to triage equivocal cervical cytology?
    Solomon D; Schiffman M
    J Natl Cancer Inst; 2004 Feb; 96(4):250-1. PubMed ID: 14970266
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a role for human papillomavirus testing in clinical practice?
    Kaufman RH
    Obstet Gynecol; 2001 Nov; 98(5 Pt 1):724-5. PubMed ID: 11704159
    [No Abstract]   [Full Text] [Related]  

  • 13. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Lynge E; Rebolj M
    J Natl Cancer Inst; 2010 May; 102(10):739; author reply 739-40. PubMed ID: 20360534
    [No Abstract]   [Full Text] [Related]  

  • 15. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease.
    Adam E; Berkova Z; Daxnerova Z; Icenogle J; Reeves WC; Kaufman RH
    Am J Obstet Gynecol; 2000 Feb; 182(2):257-64. PubMed ID: 10694321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
    Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
    Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV primary screening for cervical cancer: more pain than protection.
    Davey DD; Armenti CA
    Diagn Cytopathol; 2000 Jun; 22(6):333-5. PubMed ID: 10820524
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing cervical cancer globally by acting locally: if not now, when?
    Gage JC; Castle PE
    J Natl Cancer Inst; 2010 Oct; 102(20):1524-7. PubMed ID: 20884892
    [No Abstract]   [Full Text] [Related]  

  • 19. A new generation of studies of human papillomavirus DNA testing in cervical cancer screening.
    Franco EL
    J Natl Cancer Inst; 2009 Dec; 101(23):1600-1. PubMed ID: 19903806
    [No Abstract]   [Full Text] [Related]  

  • 20. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.